This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

  • Optimising heart failure treatment for patients on peritoneal dialysis

    Latest Article

    Optimising heart failure treatment for patients on peritoneal dialysis

    All patients with end-stage kidney disease on renal replacement therapy have increased risk of cardiovascular disease. This has been written a lot over the y...

  • DNA concept

    Testing figures alignment

  • New article 19 March 2024

  • Sacubitril/valsartan in peritoneal dialysis patients

    Sacubitril/valsartan in peritoneal dialysis patients

  • RADIANCE II: endovascular ultrasound renal denervation as a treatment for hypertension

    RADIANCE II: endovascular ultrasound renal denervation as a treatment for hypertension

  • The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

    The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

  • MyTEMP trial: Is this the end of “cooled dialysis”?

Show all articles >
alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe